Related Experiment Video
Updated: Jul 27, 2026
09:18
Feeding Experimentation Device FED: Construction and Validation of an Open-source Device for Measuring Food Intake in Rodents
Published on: February 21, 2017
8.5K
National Center for Complementary and Integrative Health Perspectives on Clinical Research Involving Natural Products
1National Center for Complementary and Integrative Health, National Institutes of Health, Bethesda, Maryland.
Summary
Dietary supplement sales are rising, but evidence for most products
Area of Science:
- Integrative medicine and health research.
- Dietary supplement clinical trials and evidence synthesis.
Background:
- Dietary supplement sales show a consistent upward trend.
- A significant portion of the American population uses these products.
- There is a notable lack of scientific evidence regarding the safety and efficacy of most dietary supplements.
Purpose of the Study:
- To outline the National Center for Complementary and Integrative Health's (NCCIH) policies and priorities for future clinical research investments in dietary supplements.
- To inform researchers and stakeholders about the NCCIH's strategic direction in evaluating supplement safety and efficacy.
Main Methods:
- The abstract does not detail specific methods but refers to the NCCIH's experience with clinical trials.
- This perspective is based on the NCCIH's accumulated experience and data from supporting a broad range of research on dietary supplements.
Main Results:
- The NCCIH's experience with clinical trials has directly influenced its current research policies and priorities.
- These established policies and priorities are guiding future NCCIH investments in the field of dietary supplement research.
Conclusions:
- The NCCIH is actively shaping its research agenda based on empirical evidence and trial outcomes.
- Future investments will prioritize research that addresses the safety and efficacy gaps in the dietary supplement market.
Related Concept Videos
02:50Combination Therapies and Personalized Medicine
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
02:50Combination Therapies and Personalized Medicine
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
01:16Clinical Trials
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
01:27Nursing Clinical Information System
Nursing Clinical Information System (NCIS)
A Nursing Clinical Information System (NCIS) is a specialized type of healthcare information system tailored to meet the unique needs of nursing practice. It incorporates the principles of nursing informatics to streamline information management and improve the quality of care delivery.
Critical attributes of NCIS include:
A Nursing Clinical Information System (NCIS) is a specialized type of healthcare information system tailored to meet the unique needs of nursing practice. It incorporates the principles of nursing informatics to streamline information management and improve the quality of care delivery.
Critical attributes of NCIS include:
01:11Clinical Trials: Overview
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...